A human papillomavirus vaccine (HPV vaccine) is recommended for young women born in 1991 or later because they prevent cervical cancer and other HPV-related cancer.
"Young women have a unique opportunity to protect themselves from cervical cancer and other HPV-induced cancer. It is now important that everyone agrees to approach the latest deadline for launching a free HPV vaccine in a temporary vaccination program," said Gro Abrahamsen, former health worker and now head of health and health care services in Frogno. He has ordered many vaccine doses and hopes for great impressions in November and December.
The HPV vaccine consists of three doses of vaccine. Those who are in the process of vaccination by the end of December 2018 can complete vaccination by the end of June 2019, without having to pay for it. From the first and the last dose there are six months, and the first dose is the end of December.
Frogn and Nesodden
Vroginering in Frogno takes place at a health center for young people who are open Monday to 15-18. In Nesodden, time has to be ordered at the Nesoddtangen Health Center and vaccination takes place on Monday 14-16 at Berger Health Center.
Those who are "required" are girls who did not receive the HPV 7th grade vaccine through a school vaccination program where the vaccine was offered from the school year 2009/2010. The first ones who received the offer were girls born in 1996, today 21 to 22 years. Those who now have the last free chance are mostly women aged 22 to 27 – born between 1991 and 1996. Two thirds of this age group in Frogna have not taken advantage of this offer, explains Gro Abrahamsen.
"The ones we are looking for now are those that run out when it comes to getting an HPV vaccine," explains the nurse.
Waiting for next year, three doses cost more than 3,000 crowns.
Inflicted with sexual contact
Human papillomavirus (HPV) is very common and 70 percent of sexually active persons are infected with HPV during their lifetime, most of whom are at an early age. In the Norwegian survey, about 45 percent of women in the 21st century had persistent HPV infection. Most HPV infections do not give any symptoms and pass by themselves, but about 10 percent will have a long-term infection. Long-term infection with some types of HPV can lead to the development of cervical cancer and other HPV-related cancers.
In Norway there are about 350 women who receive cervical cancer due to an HPV virus per year and 60 to 100 deaths. More than 3,000 women are treated for severe precursors of cervical cancer to avoid further development of cancer.
Starting from autumn, the HPV vaccine school for the first time also became a bidding for the 7th grade boys. Like girls, almost 90 percent of the boys said the vaccine was.
"An important additional information is that we offer HPV vaccine free of charge to young men who have sex with men in Frog this year. This applies to those born in 1991 and later but here we are a bit more flexible by age," said Abrahamsen, who received several asked the boy.
Like all other vaccines, HPV vaccine can also cause side effects. The most commonly reported adverse reactions are swelling and tenderness in the arm where the vaccine is set, as well as headache. There are also reports of fever, vomiting, diarrhea and abdominal pain, unconsciousness, and powerlessness.
"Reported adverse events are expected, and the benefits of vaccine delivery are far greater than the possible disadvantages. There is no basis for changing recommendations on using HPV vaccines," the Norwegian Medical Agency reports in his report. You will find more about side effects after the HPV vaccine at FHI.
The figures from the National SYSVAK Contest show that more than 105,000 women received a free HPV vaccine bid since its launch on November 1, 2016. Additionally, cca. 180,000 girls were vaccinated through the school program.
Some facts about HPV vaccine
Offered HPV vaccine provides direct protection from the two most common types of cancerous HPV, as well as providing good protection against other cancerous HPV types.
- The HPV vaccine offered to young women is called Cervarix.
- The vaccine is recommended if you have not had one or more sexual partners.
- The vaccine is put in the form of a syringe in the upper hand.
- Authorities have approved the vaccine based on a thorough assessment of the effects and side effects.
- The vaccine provides protection from HPV types, which together causes about 90 percent of all cervical cancer cases in Norway.